Windtree Therapeutics, Inc. (WINT)
0.0169
0.00 (0.00%)
USD |
OTCM |
Apr 17, 16:00
Windtree Therapeutics SG&A Expense (Quarterly) : 1.855M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 12.30M |
| Curis, Inc. | 2.883M |
| Plus Therapeutics, Inc. | 4.168M |
| Halozyme Therapeutics, Inc. | 77.03M |
| AIM ImmunoTech, Inc. | 1.87M |